426 related articles for article (PubMed ID: 6230668)
1. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Weis JJ; Tedder TF; Fearon DT
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
[TBL] [Abstract][Full Text] [Related]
2. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
[TBL] [Abstract][Full Text] [Related]
3. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
4. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
5. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
Lambris JD; Dobson NJ; Ross GD
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1828-32. PubMed ID: 6101236
[TBL] [Abstract][Full Text] [Related]
6. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
Iida K; Nadler L; Nussenzweig V
J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
[TBL] [Abstract][Full Text] [Related]
7. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
Ross GD; Lambris JD
J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
9. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
Myones BL; Ross GD
Complement; 1987; 4(2):87-98. PubMed ID: 3497773
[TBL] [Abstract][Full Text] [Related]
10. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
Micklem KJ; Sim RB; Sim E
Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Fingeroth JD; Weis JJ; Tedder TF; Strominger JL; Biro PA; Fearon DT
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4510-4. PubMed ID: 6087328
[TBL] [Abstract][Full Text] [Related]
12. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
[TBL] [Abstract][Full Text] [Related]
14. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antihuman-B-cell antibody BL13 as an anti-C3d-receptor (CR2) antibody.
Cohen JH; Fischer E; Kazatchkine MD; Brochier J; Revillard JP
Scand J Immunol; 1986 Mar; 23(3):279-85. PubMed ID: 2419969
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
[TBL] [Abstract][Full Text] [Related]
17. Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes.
Frade R
Mol Immunol; 1986 Nov; 23(11):1249-53. PubMed ID: 2950318
[TBL] [Abstract][Full Text] [Related]
18. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
Mold C; Cooper NR; Nemerow GR
J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
[TBL] [Abstract][Full Text] [Related]
20. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).
Hogg N; Ross GD; Jones DB; Slusarenko M; Walport MJ; Lachmann PJ
Eur J Immunol; 1984 Mar; 14(3):236-43. PubMed ID: 6368248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
